English
Home > Products > CAS:175865-59-5

China CAS:175865-59-5 Manufacturer

The key to our success is "Good Products Good quality, Reasonable Price and Efficient Service" for CAS:175865-59-5, In order to expand our international market, we mainly supply our oversea customers Top quality performance products and service.
CAS:175865-59-5, We hope to have long-term cooperation relationships with our clients. If you are interested in any of our items, be sure to do not hesitate to send enquiry to us/company name. We ensure that you can be totally satisfied with our best solutions!

Related Products

Hot Products

  • Budesonide

    Budesonide

    Budesonide has USP, EP specifications. CEP, GMP and FDA approved.

    CAS:51333-22-3

  • DHEA (Prasterone)

    DHEA (Prasterone)

    DHEA (Prasterone) has FP and In-house specification. DMF and WC available.

    CAS:53-43-0

  • Estriol

    Estriol

    Estriol has CP, EP, USP specifications. DMF under filing.

    CAS:50-27-1

  • Fluticasone Propionate

    Fluticasone Propionate

    Fluticasone propionate has CP, EP and USP specifications. DMF available.

    CAS:80474-14-2

  • Eslicarbazepine Acetate

    Eslicarbazepine Acetate

    Eslicarbazepine Acetate has In-house specification. DMF approved.

    CAS:236395-14-5

  • Abiraterone

    Abiraterone

    Abiraterone is a steroidal cytochrome P 450 17α-hydroxylase-17,20-lyase inhibitor (CYP17), It is used in combination with prednisone to treat patients with metastatic castration-resistant prostate cancer (prostate cancer that is resistant to medical or surgical treatments that lower testosterone and has already spread to other parts of the body) and metastatic high-risk castration-sensitive prostate cancer.

    CAS:154229-19-3

  • Related Blog
  • Reviews

  • 2021 API Exhibition Wuhan

    October 2021
    API China is a well-established comprehensive pharmaceuticals and chemicals show in Chinese pharmaceutical industry. With more than 40 years’ experience in China, it has been a well-known celebration for all parties involved in Chinese Pharmaceutical market.

  • Welcome to Xi'an API 2024

    The 91th API China & PHARMEX & PHARMPACK & SINOPHEX will be held at National Exhibition and Convention Center (Xi’an) from October 16 to 18, our booth number is 3A08.

  • What Is Epiandrosterone and Why Is It Becoming Popular in Modern Hormone Research

    In recent years, Epiandrosterone has gained increasing attention in biochemical research, pharmaceutical development, and hormone metabolism studies. As a naturally occurring androgen metabolite, this compound plays an important role in steroid biosynthesis and endocrine pathways. Scientists and manufacturers are exploring its potential applications in hormone research, biochemical analysis, and advanced pharmaceutical intermediates.

  • Why Is Intermediates Category So Important in Modern Pharmaceutical Manufacturing?

    When buyers search for an Intermediates Category supplier, they are rarely looking for a catalog page alone. They want consistency, traceability, dependable scale-up, and confidence that every stage before the final active ingredient has been handled with discipline.

  • Why Does an APIs Category Matter So Much When Choosing a Pharmaceutical Supplier?

    When buyers search for dependable pharmaceutical raw material partners, they often focus on price, lead time, and product availability first. In my experience, that approach can overlook a more important signal: how a supplier structures its APIs Category.

  • How Can the Right Intermediates Category Simplify Pharmaceutical Sourcing?

    Selecting the right Intermediates Category is more than browsing a product list. For many buyers, it shapes sourcing speed, technical communication, documentation efficiency, batch consistency, and long-term supply confidence.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept